Oncology nurse pride How Have Your Family Experiences With Cancer Impacted Your Decision to Become an Oncology Nurse? June 09, 2017
Genetics & genomics The Story of Henrietta Lacks Sheds Light on Ethical Considerations in Genetic Testing April 28, 2017
Topic Adverse events U.S. Food and Drug Administration (FDA) FDA Approves Betrixaban for Extended Duration Prophylaxis of Venous Thromboembolism On June 23, 2017, the U.S. Food and Drug Administration (FDA) approved betrixaban (Bevyxxa, Portola) for the prophylaxis of venous thromboembolism (VTE) in adult patients hospitalized for an acute medical illness who are at risk for thromboembolic complications due to moderate or severe restricted mobility and other risk factors for VTE. June 23, 2017 Immunotherapy Nursing Considerations for Adverse Events From CAR T-Cell Therapy Chimeric antigen receptor (CAR) T-cell therapy offers options for pediatric patients with relapsed or refractory acute lymphoblastic leukemia, but it comes with a unique set of side effects that can range from mild to severe. As the primary patient providers, oncology nurses are often the first to identify signs and symptoms of adverse events and acute changes in patients’ status. Understanding what to watch for can improve outcomes and help nurses deliver safe, effective care. May 09, 2017 ONS Congress Handoff Tool Promotes Nurse-to-Nurse Communication to Avoid Patient Adverse Events RuthAnn Gordon, MSN,FNP-BC, OCN®, from Memorial Sloan-Kettering Cancer Center in New York, and co-authors presented the findings during a poster session at the ONS 42nd Annual Congress in Denver, CO. The poster was titled “Utilizing Nurse to Nurse Handoff Communication to Manage Immune Related Adverse Events in an Outpatient Immunotherapy Clinic.” May 05, 2017 ONS Congress Educational Initiative Increases Nurse Understanding of Infusion-Related Reactions and Interventions Denise Portz, MSN, RN, AOCNS®, ACNS-BC, a clinical nurse specialist at the Froedtert Hospital in Wisconsin, presented the findings during a poster session at the ONS 42nd Annual Congress in Denver, CO. The poster was titled “Providing Oncology Infusion Nurses Evidence-Based Guidelines and Interventions to Manage Infusion Reactions and Anaphylaxis.” May 05, 2017 Adverse events Sorafenib Adverse Events May Be More Common in Thyroid Cancer Researchers have found that patients receiving sorafenib for differential thyroid cancer are more likely to experience adverse events from the drug, compared to patients with renal or hepatocellular cancers. The findings were published in JAMA Oncology. July 19, 2016 Adverse events Antiemetics for Nausea and Vomiting Simplified As oncology nurses, we must have a solid understanding of and a certain comfort level with the use of antiemetics. It seems easy to get stuck in a routine that revolves around one or two drugs for all of our patients. However, antiemetic regimens need to be just as individualized for patients as their chemotherapy regimens. July 14, 2015 Adverse events What Do Oncology Nurses Need to Know About Blood Transfusions for Anemia? Approximately 90% of patients with cancer experience anemia because of disease process, treatment side effects, or coexisting conditions. June 02, 2015 Adverse events Reduce Complications in High-Risk Patients With Cancer Emergencies in high-risk patients with cancer can lead to complications, and nurses are often the first line of defense to recognize signs and symptoms and initiate a therapeutic response. April 25, 2015 Adverse events The Case of the Cannabis Conundrum Derek is a 20-year-old patient with relapsed acute myeloid leukemia. He will be receiving a bone marrow transplant in the next six days. When discussing Derek’s home medications, he says to the nurse, “I smoke a lot of pot because it helps me feel better about all of this.” Upon further discussion, Derek reveals he started smoking marijuana to relieve nausea. What would you do? December 02, 2014 Adverse events Manage Immune-Related Adverse Events Associated With Cancer Immunotherapies The FDA approved two new immunomodulatory agents, sipuleucel-T and ipilimumab, in 2010 and 2011, respectively. Sipuleucel-T was approved to treat metastatic prostate cancer, and ipilimumab was approved for advanced or metastatic melanoma. September 09, 2014 Adverse events The Case of the Vexing Vesicant Ursula arrives in her physician’s office to receive doxorubicin and cyclophosphamide October 04, 2012 Adverse events Symptom Clusters in Women With Lung Cancer Symptoms of lung cancer rarely occur in isolation January 02, 2012 Adverse events Nursing Care of Tenckhoff Catheters for Malignant Pleural Effusions Malignant pleural effusion is a frequent and often morbid side effect of advanced metastatic disease, and its symptoms may cause anxiety and emotional distress for patients as well as their families. March 01, 2010 Trending Topics Safety Standards Research Treatments ONS Congress Clinical practice Immunotherapy U.S. Food and Drug Administration (FDA) Cancer research Nursing education View All Topics
U.S. Food and Drug Administration (FDA) FDA Approves Betrixaban for Extended Duration Prophylaxis of Venous Thromboembolism On June 23, 2017, the U.S. Food and Drug Administration (FDA) approved betrixaban (Bevyxxa, Portola) for the prophylaxis of venous thromboembolism (VTE) in adult patients hospitalized for an acute medical illness who are at risk for thromboembolic complications due to moderate or severe restricted mobility and other risk factors for VTE. June 23, 2017
Immunotherapy Nursing Considerations for Adverse Events From CAR T-Cell Therapy Chimeric antigen receptor (CAR) T-cell therapy offers options for pediatric patients with relapsed or refractory acute lymphoblastic leukemia, but it comes with a unique set of side effects that can range from mild to severe. As the primary patient providers, oncology nurses are often the first to identify signs and symptoms of adverse events and acute changes in patients’ status. Understanding what to watch for can improve outcomes and help nurses deliver safe, effective care. May 09, 2017
ONS Congress Handoff Tool Promotes Nurse-to-Nurse Communication to Avoid Patient Adverse Events RuthAnn Gordon, MSN,FNP-BC, OCN®, from Memorial Sloan-Kettering Cancer Center in New York, and co-authors presented the findings during a poster session at the ONS 42nd Annual Congress in Denver, CO. The poster was titled “Utilizing Nurse to Nurse Handoff Communication to Manage Immune Related Adverse Events in an Outpatient Immunotherapy Clinic.” May 05, 2017
ONS Congress Educational Initiative Increases Nurse Understanding of Infusion-Related Reactions and Interventions Denise Portz, MSN, RN, AOCNS®, ACNS-BC, a clinical nurse specialist at the Froedtert Hospital in Wisconsin, presented the findings during a poster session at the ONS 42nd Annual Congress in Denver, CO. The poster was titled “Providing Oncology Infusion Nurses Evidence-Based Guidelines and Interventions to Manage Infusion Reactions and Anaphylaxis.” May 05, 2017
Adverse events Sorafenib Adverse Events May Be More Common in Thyroid Cancer Researchers have found that patients receiving sorafenib for differential thyroid cancer are more likely to experience adverse events from the drug, compared to patients with renal or hepatocellular cancers. The findings were published in JAMA Oncology. July 19, 2016
Adverse events Antiemetics for Nausea and Vomiting Simplified As oncology nurses, we must have a solid understanding of and a certain comfort level with the use of antiemetics. It seems easy to get stuck in a routine that revolves around one or two drugs for all of our patients. However, antiemetic regimens need to be just as individualized for patients as their chemotherapy regimens. July 14, 2015
Adverse events What Do Oncology Nurses Need to Know About Blood Transfusions for Anemia? Approximately 90% of patients with cancer experience anemia because of disease process, treatment side effects, or coexisting conditions. June 02, 2015
Adverse events Reduce Complications in High-Risk Patients With Cancer Emergencies in high-risk patients with cancer can lead to complications, and nurses are often the first line of defense to recognize signs and symptoms and initiate a therapeutic response. April 25, 2015
Adverse events The Case of the Cannabis Conundrum Derek is a 20-year-old patient with relapsed acute myeloid leukemia. He will be receiving a bone marrow transplant in the next six days. When discussing Derek’s home medications, he says to the nurse, “I smoke a lot of pot because it helps me feel better about all of this.” Upon further discussion, Derek reveals he started smoking marijuana to relieve nausea. What would you do? December 02, 2014
Adverse events Manage Immune-Related Adverse Events Associated With Cancer Immunotherapies The FDA approved two new immunomodulatory agents, sipuleucel-T and ipilimumab, in 2010 and 2011, respectively. Sipuleucel-T was approved to treat metastatic prostate cancer, and ipilimumab was approved for advanced or metastatic melanoma. September 09, 2014
Adverse events The Case of the Vexing Vesicant Ursula arrives in her physician’s office to receive doxorubicin and cyclophosphamide October 04, 2012
Adverse events Symptom Clusters in Women With Lung Cancer Symptoms of lung cancer rarely occur in isolation January 02, 2012
Adverse events Nursing Care of Tenckhoff Catheters for Malignant Pleural Effusions Malignant pleural effusion is a frequent and often morbid side effect of advanced metastatic disease, and its symptoms may cause anxiety and emotional distress for patients as well as their families. March 01, 2010
